NEW YORK--(BUSINESS WIRE)--The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against MiMedx Group, Inc. (NASDAQ:MDXG) resulting from reports that the FDA notified the Company that it is unlawfully manufacturing drugs at one of its plants.
The Rosen Law Firm is preparing a securities class action lawsuit on behalf of MiMedx investors to recover investors’ losses. If you purchased or acquired MiMedx on or before September 4, 2013, please go to the website at http://rosenlegal.com for more information. You may also contact Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.